Monika Hunjadi, Ph.D., is currently a Postdoctoral Researcher at the Institute of Animal Cell Technology and Systems Biology, Department of Biotechnology, University of Natural Resources and Life Sciences. She received her Ph.D. in "HDL Mediated Cholesterol Efflux and its Influence on Atherosclerosis" from the Medical University of Innsbruck in 2019, with distinction. Dr. Hunjadi's research focuses on the bioprocess engineering of mammalian cells and mammalian cell factory design. She has also worked as a Junior Postdoc in the Gene Therapy Laboratory at the Medical University of Innsbruck, where she conducted research on viral gene transfer and modulation of the HDL-mediated reverse cholesterol transport and its effect on atherogenesis. Dr. Hunjadi is a member of the Austrian Association of Molecular Life Sciences and Biotechnology (OEGMBT) and the European Society for Animal Cell Technology (ESACT).